https://www.selleckchem.com/pr....oducts/Rapamycin.htm
Disseminated infection due to non-tuberculous mycobacteria has been a major factor of mortality and comorbidity in HIV patients. Until 2018, U.S. American guidelines have recommended antimycobacterial prophylaxis in patients with low CD4 cell counts, a practice that has not been adopted in Europe. This study aimed at examining the impact of disseminated NTM disease on clinical outcome in German HIV patients with a severe immunodeficiency. In this retrospective case control study, HIV patients with disseminated NTM disease were identif
إعجاب
علق
شارك
